Study Condition(s): Non-small Cell Lung Cancer

A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC

Study Alias: JFCP

Study Identifier(s): Tool Tip Icon {{ defaultRegistry.registryAnchorText }} NCT02392507 {{ currentLocaleObject.registryAnchorText }}

Study Purpose

The purpose of the study is to determine if nab-paclitaxel and carboplatin chemotherapy plus necitumumab is effective and safe in participants with stage IV squamous non-small cell lung cancer.

Key Participation Requirements Tool Tip Icon

All clinical trials have rules about who can participate. This section outlines some of those rules. Please contact a study center to discuss the full set of criteria

Gender

Male Female

Age

18+ years

Time Commitment

You can participate in this study for as long as your study doctor determines that you are benefiting from the study treatment.
  • Participant must have Stage IV Squamous Non-Small Cell lung cancer confirmed by histology or cytology

  • Participant must not be enrolled in another clinical trial

  • Participant must not have undergone systemic radiotherapy, major surgery or received any investigational therapy within 4 weeks prior to study entry

  • Participant must not have a history of arterial or venous embolism within 6 months prior to study entry

  • Participant must have discontinued any investigational product or non approved use of a drug or device from a clinical trial more than 30 days prior to the first day of study treatment

  • Participant must not have received previous chemotherapy for advanced NSCLC, however participants who have received adjuvant or neoadjuvant chemotherapy are eligible if the last administration of the prior regimens occurred at least 1 year prior to study entry

  • Female participant must not be pregnant or breastfeeding

Where to Participate

19 locations are currently available of 19 planned
Invalid Postal Code.
Please re-enter postal code.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location Status
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Status {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus | translate}}
Closest Location to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Status {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus | translate}}
Other Location(s) to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Status {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus | translate}} {{site.getSiteCTALabel() | translate}}

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.